nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PTGR2—medulla oblongata—narcolepsy	0.0238	0.0688	CbGeAlD
Indomethacin—PTGR2—midbrain—narcolepsy	0.0218	0.0629	CbGeAlD
Indomethacin—PTGDR2—brain—narcolepsy	0.0206	0.0595	CbGeAlD
Indomethacin—GLO1—forebrain—narcolepsy	0.0204	0.0588	CbGeAlD
Indomethacin—GLO1—medulla oblongata—narcolepsy	0.0147	0.0425	CbGeAlD
Indomethacin—PTGR2—brain—narcolepsy	0.0137	0.0395	CbGeAlD
Indomethacin—CXCL8—medulla oblongata—narcolepsy	0.0136	0.0391	CbGeAlD
Indomethacin—GLO1—midbrain—narcolepsy	0.0135	0.0388	CbGeAlD
Indomethacin—PLA2G2A—midbrain—narcolepsy	0.0125	0.0361	CbGeAlD
Indomethacin—CXCL8—midbrain—narcolepsy	0.0124	0.0357	CbGeAlD
Indomethacin—PTGDR2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.011	0.0169	CbGpPWpGaD
Indomethacin—PTGDR2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0106	0.0163	CbGpPWpGaD
Indomethacin—AKR1C3—medulla oblongata—narcolepsy	0.0106	0.0307	CbGeAlD
Indomethacin—PPARG—forebrain—narcolepsy	0.00973	0.0281	CbGeAlD
Indomethacin—AKR1C3—midbrain—narcolepsy	0.00971	0.028	CbGeAlD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00945	0.0145	CbGpPWpGaD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00945	0.0145	CbGpPWpGaD
Indomethacin—SLCO1A2—forebrain—narcolepsy	0.00918	0.0265	CbGeAlD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00912	0.014	CbGpPWpGaD
Indomethacin—CXCL8—AP-1 transcription factor network—PENK—narcolepsy	0.00893	0.0137	CbGpPWpGaD
Indomethacin—ABCC4—forebrain—narcolepsy	0.00884	0.0255	CbGeAlD
Indomethacin—PTGDR2—G alpha (i) signalling events—PENK—narcolepsy	0.0087	0.0133	CbGpPWpGaD
Indomethacin—GLO1—brain—narcolepsy	0.00846	0.0244	CbGeAlD
Indomethacin—PLA2G2A—brain—narcolepsy	0.00786	0.0227	CbGeAlD
Indomethacin—CXCL8—brain—narcolepsy	0.00778	0.0225	CbGeAlD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00776	0.0119	CbGpPWpGaD
Indomethacin—PPARA—brain—narcolepsy	0.00734	0.0212	CbGeAlD
Indomethacin—PTGDR2—GPCR ligand binding—HCRTR2—narcolepsy	0.00719	0.011	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR ligand binding—HCRTR1—narcolepsy	0.00719	0.011	CbGpPWpGaD
Indomethacin—ABCC4—Ectoderm Differentiation—SOCS2—narcolepsy	0.00707	0.0108	CbGpPWpGaD
Indomethacin—SLC10A1—brain—narcolepsy	0.00706	0.0204	CbGeAlD
Indomethacin—PTGDR2—GPCR ligand binding—P2RY11—narcolepsy	0.00695	0.0106	CbGpPWpGaD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00691	0.0106	CbGpPWpGaD
Indomethacin—SLCO1A2—medulla oblongata—narcolepsy	0.00663	0.0191	CbGeAlD
Indomethacin—PTGDR2—G alpha (i) signalling events—HRH3—narcolepsy	0.00648	0.00992	CbGpPWpGaD
Indomethacin—SLC22A7—brain—narcolepsy	0.00629	0.0182	CbGeAlD
Indomethacin—AKR1C3—brain—narcolepsy	0.0061	0.0176	CbGeAlD
Indomethacin—SLC22A6—brain—narcolepsy	0.00608	0.0175	CbGeAlD
Indomethacin—SLCO1A2—midbrain—narcolepsy	0.00606	0.0175	CbGeAlD
Indomethacin—PTGDR2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00602	0.00921	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR ligand binding—HCRT—narcolepsy	0.00591	0.00904	CbGpPWpGaD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00588	0.009	CbGpPWpGaD
Indomethacin—PPARA—Circadian rythm related genes—HCRTR2—narcolepsy	0.00576	0.00882	CbGpPWpGaD
Indomethacin—PPARA—Circadian rythm related genes—HCRTR1—narcolepsy	0.00576	0.00882	CbGpPWpGaD
Indomethacin—CXCL8—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.00549	0.0084	CbGpPWpGaD
Indomethacin—CXCL8—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.00549	0.0084	CbGpPWpGaD
Indomethacin—CES1—brain—narcolepsy	0.00545	0.0157	CbGeAlD
Indomethacin—PTGDR2—GPCR ligand binding—PENK—narcolepsy	0.00526	0.00806	CbGpPWpGaD
Indomethacin—PTGS1—forebrain—narcolepsy	0.0052	0.015	CbGeAlD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00515	0.00789	CbGpPWpGaD
Indomethacin—PTGS2—forebrain—narcolepsy	0.00497	0.0144	CbGeAlD
Indomethacin—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.00486	0.00744	CbGpPWpGaD
Indomethacin—ALB—FOXA2 and FOXA3 transcription factor networks—CPT1B—narcolepsy	0.00484	0.0074	CbGpPWpGaD
Indomethacin—CXCL8—Peptide ligand-binding receptors—HCRT—narcolepsy	0.00451	0.00689	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00449	0.00688	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR ligand binding—TRH—narcolepsy	0.00448	0.00685	CbGpPWpGaD
Indomethacin—ABCC3—brain—narcolepsy	0.00444	0.0128	CbGeAlD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00427	0.00654	CbGpPWpGaD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00427	0.00654	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—HCRTR2—narcolepsy	0.00413	0.00632	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—HCRTR1—narcolepsy	0.00413	0.00632	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00406	0.00622	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00406	0.00622	CbGpPWpGaD
Indomethacin—CXCL8—Overview of nanoparticle effects—TNF—narcolepsy	0.00405	0.0062	CbGpPWpGaD
Indomethacin—PPARG—brain—narcolepsy	0.00404	0.0117	CbGeAlD
Indomethacin—CXCL8—Peptide ligand-binding receptors—PENK—narcolepsy	0.00402	0.00615	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—P2RY11—narcolepsy	0.00393	0.00601	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR ligand binding—HRH3—narcolepsy	0.00393	0.00601	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—HLA-DQA1—narcolepsy	0.00385	0.0059	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00382	0.00585	CbGpPWpGaD
Indomethacin—SLCO1A2—brain—narcolepsy	0.00381	0.011	CbGeAlD
Indomethacin—ALB—brain—narcolepsy	0.00379	0.0109	CbGeAlD
Indomethacin—PTGDR2—Signaling by GPCR—HCRTR1—narcolepsy	0.00369	0.00565	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—HCRTR2—narcolepsy	0.00369	0.00565	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00368	0.00563	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00368	0.00563	CbGpPWpGaD
Indomethacin—ABCC4—brain—narcolepsy	0.00367	0.0106	CbGeAlD
Indomethacin—SLC22A8—brain—narcolepsy	0.00364	0.0105	CbGeAlD
Indomethacin—CXCL8—Allograft Rejection—HLA-DQB1—narcolepsy	0.0036	0.00551	CbGpPWpGaD
Indomethacin—PTGS2—medulla oblongata—narcolepsy	0.00359	0.0104	CbGeAlD
Indomethacin—PTGDR2—Signaling by GPCR—P2RY11—narcolepsy	0.00357	0.00546	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00355	0.00544	CbGpPWpGaD
Indomethacin—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.00348	0.00533	CbGpPWpGaD
Indomethacin—CXCL8—EBV LMP1 signaling—TNF—narcolepsy	0.00348	0.00532	CbGpPWpGaD
Indomethacin—PPARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—narcolepsy	0.00346	0.0053	CbGpPWpGaD
Indomethacin—CXCL8—Peptide ligand-binding receptors—TRH—narcolepsy	0.00341	0.00522	CbGpPWpGaD
Indomethacin—CXCL8—G alpha (i) signalling events—PENK—narcolepsy	0.00339	0.00518	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—HCRT—narcolepsy	0.00334	0.00511	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00329	0.00503	CbGpPWpGaD
Indomethacin—PTGS2—midbrain—narcolepsy	0.00328	0.00948	CbGeAlD
Indomethacin—PTGDR2—GPCR ligand binding—NPS—narcolepsy	0.00325	0.00498	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR ligand binding—TAC1—narcolepsy	0.00325	0.00498	CbGpPWpGaD
Indomethacin—ABCC1—brain—narcolepsy	0.00313	0.00902	CbGeAlD
Indomethacin—ABCB1—forebrain—narcolepsy	0.00308	0.00888	CbGeAlD
Indomethacin—PLA2G2A—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00305	0.00467	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—HCRT—narcolepsy	0.00303	0.00464	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00302	0.00462	CbGpPWpGaD
Indomethacin—PLA2G2A—Cardiac Hypertrophic Response—TNF—narcolepsy	0.003	0.00459	CbGpPWpGaD
Indomethacin—PTGDR2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.003	0.00459	CbGpPWpGaD
Indomethacin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.00299	0.00458	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—PENK—narcolepsy	0.00298	0.00455	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.0029	0.00445	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00285	0.00436	CbGpPWpGaD
Indomethacin—PPARG—Transcription factor regulation in adipogenesis—TNF—narcolepsy	0.00284	0.00434	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—HCRTR2—narcolepsy	0.0028	0.00429	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—HCRTR1—narcolepsy	0.0028	0.00429	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—HLA-DRB1—narcolepsy	0.00274	0.00419	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—P2RY11—narcolepsy	0.00271	0.00414	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—PENK—narcolepsy	0.0027	0.00413	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00269	0.00412	CbGpPWpGaD
Indomethacin—PPARA—Circadian rythm related genes—NPS—narcolepsy	0.00261	0.00399	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.0026	0.00397	CbGpPWpGaD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00257	0.00393	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—TRH—narcolepsy	0.00253	0.00387	CbGpPWpGaD
Indomethacin—CXCL8—G alpha (i) signalling events—HRH3—narcolepsy	0.00253	0.00387	CbGpPWpGaD
Indomethacin—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—narcolepsy	0.00248	0.0038	CbGpPWpGaD
Indomethacin—CXCL8—Peptide ligand-binding receptors—NPS—narcolepsy	0.00248	0.0038	CbGpPWpGaD
Indomethacin—CXCL8—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00248	0.0038	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—HCRT—narcolepsy	0.0023	0.00352	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—TRH—narcolepsy	0.0023	0.00352	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00229	0.0035	CbGpPWpGaD
Indomethacin—PTGS1—Overview of nanoparticle effects—TNF—narcolepsy	0.00223	0.00342	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00223	0.00342	CbGpPWpGaD
Indomethacin—ABCB1—medulla oblongata—narcolepsy	0.00222	0.00641	CbGeAlD
Indomethacin—PTGDR2—GPCR downstream signaling—HRH3—narcolepsy	0.00222	0.00339	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—HCRTR2—narcolepsy	0.00218	0.00334	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—HCRTR1—narcolepsy	0.00218	0.00334	CbGpPWpGaD
Indomethacin—PTGS1—brain—narcolepsy	0.00216	0.00623	CbGeAlD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00216	0.0033	CbGpPWpGaD
Indomethacin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—TNF—narcolepsy	0.00214	0.00327	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—P2RY11—narcolepsy	0.00211	0.00322	CbGpPWpGaD
Indomethacin—PTGS2—brain—narcolepsy	0.00206	0.00595	CbGeAlD
Indomethacin—CXCL8—GPCR ligand binding—PENK—narcolepsy	0.00205	0.00314	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00204	0.00312	CbGpPWpGaD
Indomethacin—ABCB1—midbrain—narcolepsy	0.00203	0.00586	CbGeAlD
Indomethacin—PTGDR2—Signaling by GPCR—HRH3—narcolepsy	0.00201	0.00308	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00201	0.00307	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—CHKB—narcolepsy	0.002	0.00306	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR ligand binding—HTR2A—narcolepsy	0.00196	0.00299	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00194	0.00296	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00188	0.00288	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—NPS—narcolepsy	0.00187	0.00286	CbGpPWpGaD
Indomethacin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—narcolepsy	0.00187	0.00286	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—TAC1—narcolepsy	0.00184	0.00281	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—NPS—narcolepsy	0.00184	0.00281	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—CTNNBL1—narcolepsy	0.00183	0.0028	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—HCRT—narcolepsy	0.00179	0.00274	CbGpPWpGaD
Indomethacin—PTGS2—Overview of nanoparticle effects—TNF—narcolepsy	0.00177	0.00271	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00175	0.00268	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00175	0.00267	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—TRH—narcolepsy	0.00174	0.00267	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—CHKB—narcolepsy	0.0017	0.0026	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00169	0.00259	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—TAC1—narcolepsy	0.00167	0.00255	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—NPS—narcolepsy	0.00167	0.00255	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00166	0.00255	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00166	0.00255	CbGpPWpGaD
Indomethacin—PLA2G2A—Spinal Cord Injury—TNF—narcolepsy	0.00163	0.00249	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00161	0.00246	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—PENK—narcolepsy	0.0016	0.00244	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—HCRTR1—narcolepsy	0.00158	0.00242	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—HCRTR2—narcolepsy	0.00158	0.00242	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—P2RY11—narcolepsy	0.00153	0.00234	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—HRH3—narcolepsy	0.00153	0.00234	CbGpPWpGaD
Indomethacin—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—narcolepsy	0.00147	0.00225	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00147	0.00225	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—CHKB—narcolepsy	0.00146	0.00224	CbGpPWpGaD
Indomethacin—PPARA—Transcriptional regulation of white adipocyte differentiation—TNF—narcolepsy	0.00145	0.00222	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HCRTR2—narcolepsy	0.00144	0.0022	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HCRTR1—narcolepsy	0.00144	0.0022	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00143	0.00219	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—P2RY11—narcolepsy	0.00139	0.00213	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00139	0.00212	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—CPT1B—narcolepsy	0.00136	0.00208	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TRH—narcolepsy	0.00136	0.00208	CbGpPWpGaD
Indomethacin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00135	0.00207	CbGpPWpGaD
Indomethacin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00135	0.00207	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—CTNNBL1—narcolepsy	0.00131	0.00201	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—HCRT—narcolepsy	0.0013	0.00199	CbGpPWpGaD
Indomethacin—CXCL8—Allograft Rejection—TNF—narcolepsy	0.0013	0.00198	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00128	0.00196	CbGpPWpGaD
Indomethacin—ABCB1—brain—narcolepsy	0.00128	0.00368	CbGeAlD
Indomethacin—PPARA—Metabolism—CHKB—narcolepsy	0.00127	0.00194	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—TAC1—narcolepsy	0.00127	0.00194	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—NPS—narcolepsy	0.00127	0.00194	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.0012	0.00183	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00119	0.00182	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—HRH3—narcolepsy	0.00119	0.00182	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HCRT—narcolepsy	0.00118	0.00181	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—PENK—narcolepsy	0.00116	0.00177	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—CPT1B—narcolepsy	0.00116	0.00177	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00115	0.00176	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00114	0.00174	CbGpPWpGaD
Indomethacin—PPARG—Signaling events mediated by HDAC Class I—TNF—narcolepsy	0.00112	0.00172	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.00112	0.00171	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—HTR2A—narcolepsy	0.00111	0.00169	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00109	0.00167	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HCRTR1—narcolepsy	0.00108	0.00165	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HCRTR2—narcolepsy	0.00108	0.00165	CbGpPWpGaD
Indomethacin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—narcolepsy	0.00106	0.00162	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—PENK—narcolepsy	0.00105	0.00161	CbGpPWpGaD
Indomethacin—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—narcolepsy	0.00104	0.00159	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—P2RY11—narcolepsy	0.00104	0.00159	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—HTR2A—narcolepsy	0.001	0.00154	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.001	0.00153	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—CPT1B—narcolepsy	0.000994	0.00152	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TAC1—narcolepsy	0.000986	0.00151	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—NPS—narcolepsy	0.000986	0.00151	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—TRH—narcolepsy	0.000986	0.00151	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000972	0.00149	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—CHKB—narcolepsy	0.000961	0.00147	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—CHKB—narcolepsy	0.000961	0.00147	CbGpPWpGaD
Indomethacin—PPARA—Adipogenesis—TNF—narcolepsy	0.000956	0.00146	CbGpPWpGaD
Indomethacin—CXCL8—Spinal Cord Injury—TNF—narcolepsy	0.00094	0.00144	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000918	0.00141	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—CHKB—narcolepsy	0.000909	0.00139	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—TRH—narcolepsy	0.000895	0.00137	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HCRT—narcolepsy	0.000884	0.00135	CbGpPWpGaD
Indomethacin—PTGS2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000874	0.00134	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—HRH3—narcolepsy	0.000864	0.00132	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—CPT1B—narcolepsy	0.000862	0.00132	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.000851	0.0013	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HCRTR2—narcolepsy	0.00085	0.0013	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HCRTR1—narcolepsy	0.00085	0.0013	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CHKB—narcolepsy	0.000837	0.00128	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000824	0.00126	CbGpPWpGaD
Indomethacin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—narcolepsy	0.000824	0.00126	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—P2RY11—narcolepsy	0.00082	0.00126	CbGpPWpGaD
Indomethacin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—narcolepsy	0.000818	0.00125	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PENK—narcolepsy	0.000788	0.00121	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HRH3—narcolepsy	0.000785	0.0012	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CHKB—narcolepsy	0.000781	0.0012	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CHKB—narcolepsy	0.000781	0.0012	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000772	0.00118	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—HTR2A—narcolepsy	0.000762	0.00117	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CHKB—narcolepsy	0.000753	0.00115	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000752	0.00115	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000751	0.00115	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—NPS—narcolepsy	0.000716	0.0011	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—TAC1—narcolepsy	0.000716	0.0011	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CHKB—narcolepsy	0.000716	0.0011	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HCRT—narcolepsy	0.000698	0.00107	CbGpPWpGaD
Indomethacin—PPARG—Adipogenesis—TNF—narcolepsy	0.000685	0.00105	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TRH—narcolepsy	0.00067	0.00103	CbGpPWpGaD
Indomethacin—PTGS1—Selenium Micronutrient Network—TNF—narcolepsy	0.000656	0.001	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—CPT1B—narcolepsy	0.000653	0.001	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—CPT1B—narcolepsy	0.000653	0.001	CbGpPWpGaD
Indomethacin—ALB—Vitamin B12 Metabolism—TNF—narcolepsy	0.000651	0.000997	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—NPS—narcolepsy	0.00065	0.000995	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—TAC1—narcolepsy	0.00065	0.000995	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CHKB—narcolepsy	0.000637	0.000974	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000624	0.000955	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PENK—narcolepsy	0.000622	0.000952	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—CPT1B—narcolepsy	0.000618	0.000946	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—HTR2A—narcolepsy	0.000593	0.000908	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRH3—narcolepsy	0.000588	0.000899	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CPT1B—narcolepsy	0.000569	0.000871	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00056	0.000858	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CPT1B—narcolepsy	0.000531	0.000813	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CPT1B—narcolepsy	0.000531	0.000813	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—TNF—narcolepsy	0.00053	0.000811	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TRH—narcolepsy	0.000529	0.000809	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—TNF—narcolepsy	0.00052	0.000796	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CPT1B—narcolepsy	0.000512	0.000784	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000511	0.000782	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CHKB—narcolepsy	0.000506	0.000774	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TAC1—narcolepsy	0.000487	0.000745	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NPS—narcolepsy	0.000487	0.000745	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CPT1B—narcolepsy	0.000487	0.000745	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRH3—narcolepsy	0.000464	0.000709	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CPT1B—narcolepsy	0.000433	0.000662	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—HTR2A—narcolepsy	0.000431	0.000659	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—TNF—narcolepsy	0.000421	0.000644	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—TNF—narcolepsy	0.000412	0.00063	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CHKB—narcolepsy	0.000409	0.000626	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000402	0.000615	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HTR2A—narcolepsy	0.000391	0.000599	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TAC1—narcolepsy	0.000384	0.000588	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NPS—narcolepsy	0.000384	0.000588	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CHKB—narcolepsy	0.000367	0.000562	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CHKB—narcolepsy	0.000358	0.000548	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CPT1B—narcolepsy	0.000344	0.000526	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CHKB—narcolepsy	0.000335	0.000512	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—TNF—narcolepsy	0.000328	0.000503	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HTR2A—narcolepsy	0.000293	0.000448	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.00028	0.000428	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CPT1B—narcolepsy	0.000278	0.000425	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CPT1B—narcolepsy	0.00025	0.000382	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CPT1B—narcolepsy	0.000244	0.000373	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—TNF—narcolepsy	0.000235	0.00036	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HTR2A—narcolepsy	0.000231	0.000354	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CPT1B—narcolepsy	0.000228	0.000348	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000198	0.000304	CbGpPWpGaD
